Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
THURSDAY, Jan. 30, 2025 (HealthDay News) -- People of color now have less access to prescription opioid painkillers than ...
From unexpected gender disparities to alarming teen statistics, discover essential facts about opioid medications that every ...
Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback